Protocol of the PANCALYZE trial: a multicenter, prospective study investigating the tumor biomarkers CXCR4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease
Crossref DOI link: https://doi.org/10.1186/s12885-017-3186-8
Published Online: 2017-03-29
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Popp, Felix C.
Popp, Marie Christine
Zhao, Yue
Betzler, Christopher
Kropf, Siegfried
Garlipp, Benjamin
Benckert, Christoph
Kalinski, Thomas
Lippert, Hans
Bruns, Christiane J.